Literature DB >> 17305581

Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity.

Hengming Ke1, Huanchen Wang.   

Abstract

Crystal structures of seven phosphodiesterase families (PDE1-5, 7, 9) show a conserved core catalytic domain that contains about 300 amino acids and fourteen alpha-helices. The catalytic domains of the PDE families 1-4, 7, and 9 have a uniform conformation. However, the H-loop at the active site of PDE5 shows four different conformations upon binding of inhibitors, probably implying a special mechanism for recognition of substrates and inhibitors by PDE5. The active site of all PDE families contains two divalent metal ions: zinc and probably magnesium. The PDE4-AMP and PDE5-GMP structures reveal the conserved interactions of the phosphate groups of the products AMP and GMP, and thus suggest a universal mechanism of nucleophilic attack for all PDE families. The substrate specificity has not been well understood. This review will comment on the early proposal, "glutamine switch", on basis of the recent biochemical and structural information. The PDE-inhibitor structures have identified a common subpocket for non-selective binding of all inhibitors and potential elements for recognition of family-selective inhibitors. The kinetic analysis on the mutations of PDE7 to PDE4 suggests that the multiple elements must work together to define inhibitor selectivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305581     DOI: 10.2174/156802607779941242

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  48 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Computational determination of binding structures and free energies of phosphodiesterase-2 with benzo[1,4]diazepin-2-one derivatives.

Authors:  Bo Yang; Adel Hamza; Guangju Chen; Yan Wang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-11-15       Impact factor: 2.991

Review 3.  Advances in targeting cyclic nucleotide phosphodiesterases.

Authors:  Donald H Maurice; Hengming Ke; Faiyaz Ahmad; Yousheng Wang; Jay Chung; Vincent C Manganiello
Journal:  Nat Rev Drug Discov       Date:  2014-04       Impact factor: 84.694

4.  Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer properties.

Authors:  Heba A Mohamed; Nancy M R Girgis; Rainer Wilcken; Matthias R Bauer; Heather N Tinsley; Bernard D Gary; Gary A Piazza; Frank M Boeckler; Ashraf H Abadi
Journal:  J Med Chem       Date:  2010-12-28       Impact factor: 7.446

5.  Assessing protein-ligand binding modes with computational tools: the case of PDE4B.

Authors:  Gülşah Çifci; Viktorya Aviyente; E Demet Akten; Gerald Monard
Journal:  J Comput Aided Mol Des       Date:  2017-05-22       Impact factor: 3.686

6.  Stabilization of anionic and neutral forms of a fluorophoric ligand at the active site of human carbonic anhydrase I.

Authors:  Sumathra Manokaran; Jayati Banerjee; Sanku Mallik; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2010-07-08

7.  Modulating the cyclic guanosine monophosphate substrate selectivity of the phosphodiesterase 3 inhibitors by pyridine, pyrido[2,3-d]pyrimidine derivatives and their effects upon the growth of HT-29 cancer cell line.

Authors:  Ashraf Hassan Abadi; Marwa Saeed Hany; Shimaa Awadain Elsharif; Amal Abdel Haleem Eissa; Bernard Dewayne Gary; Heather Nicole Tinsley; Gary Anthony Piazza
Journal:  Chem Pharm Bull (Tokyo)       Date:  2013       Impact factor: 1.645

8.  Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.

Authors:  De-Chen Lin; Liang Xu; Ling-Wen Ding; Arjun Sharma; Li-Zhen Liu; Henry Yang; Patrick Tan; Jay Vadgama; Beth Y Karlan; Jenny Lester; Nicole Urban; Michèl Schummer; Ngan Doan; Jonathan W Said; Hongmao Sun; Martin Walsh; Craig J Thomas; Paresma Patel; Dong Yin; Daniel Chan; H Phillip Koeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-27       Impact factor: 11.205

9.  Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.

Authors:  Zier Yan; Huanchen Wang; Jiwen Cai; Hengming Ke
Journal:  Protein Expr Purif       Date:  2008-10-19       Impact factor: 1.650

10.  Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors.

Authors:  Shilong Zheng; Gurpreet Kaur; Huanchen Wang; Minyong Li; Megan Macnaughtan; Xiaochuan Yang; Suazette Reid; James Prestegard; Binghe Wang; Hengming Ke
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.